Showing results (1121-1130 of 1,243) with videos related to

Sort By:
Pageof 125
JACC. Heart Failure|September 28, 2023
Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER TrialAlexander Peikert, Bradley A Bart, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|September 2, 2022
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trialJohn W Ostrominski, Muthiah Vaduganathan, Brian L Claggett, et al.
BMC Medical Research Methodology|September 20, 2017
Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH CollaboratoryKevin P Weinfurt, Adrian F Hernandez, Gloria D Coronado, et al.
JAMA Cardiology|February 22, 2023
Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid-Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout: A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVERJawad H Butt, Kieran F Docherty, Brian L Claggett, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Scientific Opinion on the state of the science on pesticide risk assessment for amphibians and reptiles, Colin Ockleford, Paulien Adriaanse, et al.
JACC. Asia|February 19, 2024
Effects of Dapagliflozin in Patients in Asia: A Post Hoc Subgroup Analysis From the DELIVER TrialXiaowen Wang, Carolyn S P Lam, Muthiah Vaduganathan, et al.
JACC. Heart Failure|March 6, 2025
Severe Heart Failure and Treatment With Dapagliflozin Across the Ejection Fraction Spectrum: DAPA-HF and DELIVERRiccardo M Inciardi, Henri Lu, Brian L Claggett, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 21, 2021
Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the LATAM CTO registryDagmar F Hernandez-Suarez, Lorenzo Azzalini, Francesco Moroni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2022
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant MelanomaJanice M Mehnert, Tara C Mitchell, Alexander C Huang, et al.
Diabetes Care|September 15, 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE TrialDennis I Narcisse, Hwasoon Kim, Lisa M Wruck, et al.
Pageof 125